Employment and health of people with severe mental illness
ISRCTN | ISRCTN13736301 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN13736301 |
- Submission date
- 19/03/2025
- Registration date
- 14/05/2025
- Last edited
- 01/07/2025
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
Employment is a critical pathway to recovery and community integration for people with psychotic experiences. It is a process that requires community support networks. The aim of this study was to evaluate non-vocational outcomes (symptomatology, hospital admissions, relapses, self-concept, quality of life and global functioning) when incorporating people with SMI to employment
Who can participate?
The inclusion criteria used were the following: age between 18 and 65 years, diagnosis of schizophrenia (DSM-5 TR), capacity to consent participation in the study, being clinically stable without acute psychotic symptoms or having been hospitalized during the last months, being followed by the public community mental health teams during the study and being motivated to obtain a job.
What does the study involve?
Our purpose is to know if in a context of high unemployment rates people with SMI, benefit in their results not vocations to obtain and maintain competitive employment with IPS, versus vocational Rehabilitation
What are the possible benefits and risks of participating?
None
Where is the study run from?
Canary Island (Tenerife). Spain
When is the study starting and how long is it expected to run for?
April 2024 to January 2025
Who is funding the study?
Investigator initiated and funded
Who is the main contact?
Dr Francisco Pulido, fpulido@ull.edu.es
Contact information
Scientific, Principal Investigator
Hospital Universitario de Canarias
La Laguna
38200
Spain
Phone | +34 (0)609116523 |
---|---|
fpulido@ull.edu.es |
Principal Investigator
Santa Cruz de Tenerife
Santa Cruz de Tenerife
38003
Spain
Phone | +34 (0)615912995 |
---|---|
dacilop@hotmail.com |
Public
Calle Suarez Guerra 19
Santa Cruz De Tenerife
38003
Spain
Phone | +34 (0)609752202 |
---|---|
nayra.caballero@universidadeuropea.es |
Study information
Study design | Open community-based multicenter controlled experimental randomized study |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Workplace |
Study type | Quality of life |
Participant information sheet | No participant information sheet available |
Scientific title | The impact of employment on the health of people with severe mental disorder |
Study objectives | In a context where the individual finds and maintains employment with the support of an evidence-based strategy, such as the individual placement and support (IPS) strategy, individuals with severe mental illness (SMI) who find employment will improve their non-vocational outcomes related to income, hospitalizations, and quality of life |
Ethics approval(s) |
Approved 01/04/2024, Universidad Europea De Canarias (La Orotava, Santa Cruz de Tenerife, 38005, Spain; +34 (0)609752202; nayra.caballero@universidadeuropea.es), ref: CI 2024-669 |
Health condition(s) or problem(s) studied | Severe mental illness |
Intervention | Intervention group: Individual Placement and Support strategy, developed in the United States by Becker and Drake (Becker and Drake, 1993), which states that competitive employment should be as quickly as possible based on preferences, of people wit SMI,integration with mental health team and employment technicians , followed with unlimited supports and zero exclusion. Control group: the traditional vocational strategy. Understand it is better train skills and then place people with SMI. The participants in this study were recruited from the Community Mental Health Teams (ECSM) and basic health areas. The participants were recruited from the Community Mental Health Teams (ECSM) and basic health areas. A sample size of 24 patients per group was estimated, which was increased by 30% due to possible losses to follow-up, leaving a total of 32 patients per group. A total of 557 participants were recruited from the mental health team and a total of 63 people met the selection criterio and were randomly and blindly assigned each group. At baseline and at 6-month follow-up, different test batteries were used. |
Intervention type | Other |
Primary outcome measure | Measured at baseline and 6 months: 1. Self-concept: Test de autoconcepto AF5 2. Quality of life: Test de calidad de vida de Lancashire y Escala de Satisfacción con la Vida (ESV) 3. Test Groningen Social Disabilities Schedule (GSDS) 4. Autonomy: Escala de Evaluación Global de Funcionamiento (Test Global Assessment Scale, GAF) 5. Symptomatology: Positive and Negative Syndrome Scale; Escala de ansiedad-depresión (HADS) |
Secondary outcome measures | Hospitalization: number of persons who during the last 6 months have been admitted to short- or medium-stay beds at the discretion of their regular psychiatrist measured using patient records |
Overall study start date | 01/04/2024 |
Completion date | 20/01/2025 |
Eligibility
Participant type(s) | Service user |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 65 Years |
Sex | Both |
Target number of participants | 550 |
Total final enrolment | 63 |
Key inclusion criteria | 1. Have a diagnosis of schizophrenia according to DSM-5 criteria 2. Have the capacity to consent to voluntary participation in the study, after having been informed of its objectives 3. Be clinically stable, that is, have no acute psychotic symptoms and have not been hospitalized in the last few months 4. Be monitored by the USMC Psychiatry Service (Community Mental Health Unit) during the study 5. Be motivated to obtain regular employment |
Key exclusion criteria | 1. Suffering from a common mental disorder (mood disorder) and/or other organic disorder 2. Having a history of head trauma with loss of consciousness 3. Pregnant |
Date of first enrolment | 20/06/2024 |
Date of final enrolment | 28/06/2025 |
Locations
Countries of recruitment
- Spain
Study participating centre
Santa Cruz De Tenerife
38005
Spain
Sponsor information
Other
Calle Góngora
Santa Cruz De Tenerife
38005
Spain
Phone | +34 (0)922249199 |
---|---|
sinpromi@tenerife.es | |
Website | https://sinpromi.es |
https://ror.org/040ehf661 |
Funders
Funder type
Not defined
No information available
Results and Publications
Intention to publish date | 01/05/2025 |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Data sharing statement to be made available at a later date |
Publication and dissemination plan | Planned publication in a peer-reviewed journal |
IPD sharing plan | Data will be anonymised with ethical and legal restrictions |
Editorial Notes
01/07/2025: A study contact was updated.
14/05/2025: Trial's existence confirmed by Universidad Europea De Canarias.